Major Depressive Disorder
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Attention deficit hyperactivity disorder
|
0.400 |
Biomarker
|
disease |
CTD_human |
|
|
|
ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7
|
0.400 |
SusceptibilityMutation
|
disease |
CLINVAR |
|
|
|
Involutional Depression
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Attention Deficit Disorder
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Minimal Brain Dysfunction
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Involutional paraphrenia
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Psychosis, Involutional
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
BIPOLAR AFFECTIVE DISORDER, SUSCEPTIBILITY TO
|
0.100 |
SusceptibilityMutation
|
phenotype |
CLINVAR |
|
|
|
UNIPOLAR DEPRESSION, SUSCEPTIBILITY TO
|
0.100 |
SusceptibilityMutation
|
phenotype |
CLINVAR |
|
|
|
Attention deficit hyperactivity disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
<b>Introduction:</b> Studies have documented both executive functions (EF) impairment in children with Attention Deficit / Hyperactivity Disorders (ADHD) and Theory of Mind (ToM), yielding mixed results, possibly because of a variety of tasks used, all requiring different levels of language skills.<b>Aim:</b> To investigate the relationship between ToM and EF with non-language-based tasks.<b>Methods:</b> Thirty ADHD (7-9 years old) were compared to thirty controls (age and IQ matched).
|
31661370 |
2020 |
Unipolar Depression
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.
|
19590397 |
2009 |
Major Depressive Disorder
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.
|
19590397 |
2009 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
BEFREE |
5-HTT and TPH2 variations did not contribute significantly to the prediction of interferon-induced depression by HTR1A (sensitivity, 35.9%; specificity, 84.0%).
|
17408646 |
2007 |
Mental Depression
|
0.400 |
Biomarker
|
disease |
BEFREE |
5-HTT and TPH2 variations did not contribute significantly to the prediction of interferon-induced depression by HTR1A (sensitivity, 35.9%; specificity, 84.0%).
|
17408646 |
2007 |
Depressed mood
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
5-HTT and TPH2 variations did not contribute significantly to the prediction of interferon-induced depression by HTR1A (sensitivity, 35.9%; specificity, 84.0%).
|
17408646 |
2007 |
Mood Disorders
|
0.390 |
Biomarker
|
group |
BEFREE |
TPH2, rather than TPH1, has now become a candidate gene for 5-HT-related affective disorders.
|
15968084 |
2005 |
Unipolar Depression
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide.
|
16192985 |
2006 |
Major Depressive Disorder
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide.
|
16192985 |
2006 |
Depression and Suicide
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide.
|
16192985 |
2006 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
TPH2 genotypes were determined in 69 subjects with a diagnosis of schizophrenia or bipolar disorder, among which 22 died by suicide.
|
16436194 |
2006 |
Bipolar Disorder
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
TPH2 genotypes were determined in 69 subjects with a diagnosis of schizophrenia or bipolar disorder, among which 22 died by suicide.
|
16436194 |
2006 |
Mental disorders
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tryptophan hydroxylase 2 (TPH2) was found to be solely expressed in the brain and therefore considered an important susceptibility gene in psychiatric disorders.
|
17015812 |
2006 |
Abnormal behavior
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Tryptophan hydroxylase 2 (TPH2) was found to be solely expressed in the brain and therefore considered an important susceptibility gene in psychiatric disorders.
|
17015812 |
2006 |
Autistic Disorder
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
TPH2 alleles and haplotypes are not significantly associated in our sample with autism (rs4570625: TDT P = 0.27, and FBAT P = 0.35; rs4565946: TDT P = 0.45, and FBAT P = 0.55; haplotype P = 0.84), with any endophenotype, or with the presence/absence of prominent repetitive and stereotyped behaviors (motor stereotypies: P = 0.81 and 0.84, verbal stereotypies: P = 0.38 and 0.73 for rs4570625 and rs4565946, respectively).
|
17346350 |
2007 |